Nair; Anilkumar G.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Nair; Anilkumar G..The latest application filed is for "pcsk9 antagonist compounds".
- Nair; Anilkumar G. - Rahway NJ
- Nair; Anilkumar G. - Edison NJ
| Patent | Date |
|---|---|
| PCSK9 antagonist compounds Grant 11,427,616 - Wood , et al. August 30, 2 | 2022-08-30 |
| Antidiabetic tricyclic compounds Grant 10,519,115 - Biftu , et al. Dec | 2019-12-31 |
| Pcsk9 Antagonist Compounds App 20190389909 - Wood; Harold B. ; et al. | 2019-12-26 |
| Antidiabetic tricyclic compounds Grant 10,000,454 - Biftu , et al. June 19, 2 | 2018-06-19 |
| Antidiabetic Tricyclic Compounds App 20170081287 - Biftu; Tesfaye ; et al. | 2017-03-23 |
| Antidiabetic Tricyclic Compounds App 20160257652 - Biftu; Tesfaye ; et al. | 2016-09-08 |
| Substituted 3-azabicyclo[3.1.0]hexane Derivatives Useful As Ccr2 Antagonists App 20140005165 - Nair; Anilkumar G. ; et al. | 2014-01-02 |
| Indole Derivatives Useful As Ccr2 Antagonists App 20140005174 - Nair; Anilkumar G. ; et al. | 2014-01-02 |
| Cyclohexane Substituted Amino Cyclopentane Derivatives As Useful Ccr2 Antagonists App 20130345254 - Nair; Anilkumar G. ; et al. | 2013-12-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 